Genetic etiology of type 2 diabetes mellitus: A review

International Journal of Diabetes in Developing Countries

Volumn 31, Issue 2, 2011, Pages 51-64

  Kommoju, Uma Jyothi ^a   Reddy, Battini Mohan ^a  

^a INDIAN STATISTICAL INSTITUTE   (India)

Author keywords

Candidate genes; Ethnic variability; Genome wide association scan (GWAS); Indian scenario; Insulin deficiency

Indexed keywords

EID: 80052568955     PISSN: 09733930     EISSN: 19983832     Source Type: Journal    
DOI: 10.1007/s13410-011-0020-8     Document Type: Review

References (144)

1. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a World Health Consultation. Part-1: Diagnosis and classification of Diabetesmellitus1999. Availablefrom http://whqlibdoc.who.int/ hq/1999/who-ncd-ncs-99.2.pdf
2. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of WHO/IDF Consultation, Geneva 2006. Available from http://www.who.int/diabetes/publications/Definitionanddiagnosisofdiabetes-new. pdf
3. American Diabetes Association (ADA). Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27 suppl 1:S5-10.
4. American Diabetes Association (ADA). Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008;31 suppl 1:S55-60.
5. American Diabetes Association (ADA). Diagnosis and classification of Diabetes mellitus. Diabetes Care. 2009;32 suppl 1:S62-7.
6. Ramachandran A, Snehalatha C, Viswanathan V. Burden of type 2 diabetes and its complications-The Indian scenario. Curr Sci. 2002;83:1471-6. (Pubitemid 135698195)
7. Cox NJ. Challenges in identifying genetic variation affecting susceptibility to type 2 diabetes: examples from studies of the Calpain-10 gene. Hum Mol Genet. 2001;10:2301-5. (Pubitemid 32998845)
8. American Diabetes Association (ADA). Type 2 diabetes in children and adolescents. Diabetes Care. 2000;23(3):381-9.
9. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414-31. (Pubitemid 28405191)
10. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-53. (Pubitemid 38579764)
11. Roglic G, King H. Diabetes mellitus in Asia. Hong Kong Med J. 2000;6:10-1.
12. Malecki MT, Moczulski DK, Klupa T, Wanic K, Cyganek K, Frey J, et al. Homozygous combination of calpain 10 gene haplotypes is associated with type 2 diabetes mellitus in a Polish population. Eur J Endocrinol. 2002;146:695-9. (Pubitemid 34552504)
13. Elbein SC. The genetics of human noninsulin-dependent (type 2) diabetes mellitus. J Nutr. 1997;127:1891S-6.
14. Radha V, Mohan V. Genetic predisposition to type 2 diabetes among Asian Indians. Indian J Med Res. 2007;125:259-74. (Pubitemid 46805447)
15. Flores-Martínez SE, Islas-Andrade S, Machorro-Lazo MV, Revilla MC, Juárez RE, Mújica-López KI, et al. DNA polymorphism analysis of candidate genes for type 2 diabetes mellitus in a Mexican ethnic group. Ann Génét. 2004;47:339-48. (Pubitemid 39575612)
16. Van Tilburg J, Van Haeften TW, Pearson P, Wijmenga C. Defining the genetic contribution of type 2 diabetes mellitus. J Med Genet. 2001;38:569-78. (Pubitemid 32835618)
17. Groop L, Lyssenko V. Genes and type 2 diabetes mellitus. Curr Diab Rep. 2008;8:192-7.
18. Taylor A. The genetics of type 2 diabetes: a review. Int J Diab Metab. 2006;14:76-81. (Pubitemid 46785223)
19. Fetita LS, Sobngwi E, Serradas P, Calvo F, Gautier JF. Consequences of fetal exposure to maternal diabetes in offspring. J Clin Endocrinol Metab. 2006;91:3718-24. (Pubitemid 44536834)
20. Sharma A, Chavali S, Tabassum R, Tandon N, Bharadwaj D. Gene prioritization in type 2 diabetes using domain interactions and network analysis. BMC Genomics. 2010;11:84.
21. Salonen JT, Uimari P, Aalto JM, Pirskanen M, Kaikkonen J, Todorova B, et al. Type 2 diabetes whole-genome association study in four populations: the diagen consortium. Am J Hum Genet. 2007;81:338-45. (Pubitemid 47236080)
22. Dehwah MAS, Shuang Z, Hua WZ, Min W, Qing-Yang H. Type2 diabetes: genetic advance and aetiology. J Appl Sci. 2009;9:3407-23.
23. Radha V, Vimaleswaran KS, Deepa R, Mohan V. Review article: the genetics of diabetes mellitus. Indian J Med Res. 2003;117:225-38. (Pubitemid 37461222)
24. Das SK. Genetic epidemiology of adult onset type 2 diabetes in Asian Indian population: past, present and future. Int J Hum Genet. 2006;6:1-13.
25. Zeggini E. A new era for type 2 diabetes genetics. Diabet Med. 2007;24:1181-6. (Pubitemid 47621808)
26. Ridderstrale M, Groop L. Genetic dissection of type 2 diabetes. Mol Cell Endocrinol. 2009;297:10-7.
27. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006;38:320-3.
28. Scott LJ, Bonnycastle LL, Willer CJ, Sprau AG, Jackson AU, Narisu N, et al. Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample. Diabetes. 2006;55(9):2649-53. (Pubitemid 44871169)
29. Melzer D, Murray A, Hurst AJ, Weedon MN, Bandinelli S, Corsi AM, et al. Effects of the diabetes linked TCF7L2 polymorphism in a representative older population. BMC Med. 2006;4:34.
30. Munoz J, Lok KH, Gower BA, Fernandez JR, Hunter GR, Lara-Castro C, et al. Polymorphism in the transcription factor 7-like 2 (TCF7L2) gene is associated with reduced insulin secretion in non diabetic women. Diabetes. 2006;55:3630-4. (Pubitemid 44923627)
31. Zhang C, Qi L, Hunter DJ, Meigs JB, Manson JAE, van Dam RM, et al. Variant of transcription factor 7-like 2 (tcf7l2) gene and the risk of type 2 diabetes in large cohorts of U. S. women and men. Diabetes. 2006;55:2645-8. (Pubitemid 44871168)
32. Damcott CM, Pollin TI, Reinhart LJ, Ott SH, Shen H, Silver KD, et al. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes. 2006;55:2654-9. (Pubitemid 44871170)
33. Moczulski D, Gawlik B, August R, Strojek K, Grzeszczak W. TCF7L2 gene is associated with type 2 diabetes in Polish population. Diabetologia. 2007;7:109-11. (Pubitemid 47080114)
34. Lyssenko V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, Almgren P, et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest. 2007;117:2155-63. (Pubitemid 47219560)
35. Chang YC, Chang TJ, Jiang YD, Kuo SS, Lee KC, Chui KC, et al. Association study of the genetic polymorphisms of the transcription factor 7-Like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population. Diabetes. 2007;56:2631-7.
36. Ng MC, Tam CHT, Lam VKL, Wing-Yee S, Ronald CWM, Chan JCN. Replication and identification of novel variants at tcf7l2 associated with type 2 diabetes in Hong Kong Chinese. J Clin Endocrinol Metab. 2007;92:3733-7. (Pubitemid 47435363)
37. Hayashi T, Iwamoto Y, Kaku K, Hirose H, Maeda S. Replication study for the association of TCF7L2 with susceptibility to type 2 diabetes in a Japanese population. Diabetologia. 2007;50:980-4. (Pubitemid 46559256)
38. Horikoshi M, Hara K, Ito C, Nagai R, Froguel P, Kadowaki T. A genetic variation of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetesin the Japanese population. Diabetologia. 2007;50:747-51. (Pubitemid 46355825)
39. Mayans S, Lackovic K, Lindgren P, Ruikka K, Agren A, Eliasson M, et al. TCF7L2 polymorphisms are associated with type 2 diabetes in northern Sweden. Eur J Hum Genet. 2007;15:342-6.
40. Chandak GR, Janipalli CS, Bhaskar S, Kulkarni SR, Mohankrishna P, Hattersley AT, et al. Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population. Diabetologia. 2007;50:63-7. (Pubitemid 46035854)
41. Bodhini D, Radha V, Monalisa D, Nagarajan N, Viswanathan M. The rs12255372 (G/T) and rs7903146 (C/T) polymorphisms of the TCF7L2 gene are associated with type 2 diabetes mellitus in Asian Indians. Metab Clin Exp. 2007;56:1174-8. (Pubitemid 47223256)
42. De Silva NMG, Steele A, Shields B, Knight B, Parnell K, Weedon MN, et al. The transcription factor 7-like 2 (TCF7L2) gene is associated with Type 2 diabetes in UK community-based cases, but the risk allele frequency is reduced compared with UK cases selected for genetic studies. Diabet Med. 2007;24:1067-72. (Pubitemid 47437892)
43. Van Vliet-Ostaptchouk JV, Shiri-Sverdlov R, Zhernakova A, Strengman E, Van Haeften TW, Hofker MF. Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to type 2 diabetes in the Dutch Breda cohort. Diabetologia. 2007;50:59-62. (Pubitemid 46035853)
44. Ren Q, Han XY, Wang F, Zhang XY, Han LC, Luo YY, et al. Exon sequencing and association analysis of polymorphisms in TCF7L2 with type 2 diabetes in a Chinese population. Diabetologia. 2008;51:1146-52.
45. Alsmadi O, Al-Rubeaan K, Mohamed G, Alkayal F, Al-Saud H, Al-Saud NA, et al. Weak or no association of TCF7L2 variants with type 2 diabetes risk in an Arab population. BMC Med Genet. 2008;9:72.
46. Marquezine GF, Pereira AC, Sousa AG, Mill JG, Hueb WA, Krieger JE. TCF7L2 variant genotypes and type 2 diabetes risk in Brazil: significant association, but not a significant tool for risk stratification in the general population. BMC Med Genet. 2008;9:106.
47. Rees SD, Bellary S, Britten AC, O'Hare PJ, Kumar S, Barnett AH, et al. Common variants of the TCF7L2 gene are associated with increased risk of type 2 diabetes mellitus in a UK-resident South Asian population. BMC Med Genet. 2008;9:8.
48. Fingerlin TE, Erdos MR, Watanabe RM, Wiles KR, Stringham HM, Mohlke KL, et al. Variation in three single nucleotide polymorphisms in the calpain-10 gene not associated with type 2diabetes in a large Finnish cohort. Diabetes. 2000;51:1644-8. (Pubitemid 34826638)
49. Tsai HJ, Sun G, Weeks DE, Kaushal R, Wolujewicz M, McGarvey ST, et al. Type 2 diabetes and three calpain-10 gene polymorphisms in Samoans: no evidence of association. Am J Hum Genet. 2001;69:1236-44. (Pubitemid 33124205)
50. Evans JC, Frayling TM, Cassell PG, Saker PJ, Hitman GA, Walker M, et al. Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am J Hum Genet. 2001;69:544-52. (Pubitemid 32777693)
51. Elbein SC, Chu W, Ren Q, Hemphill C, Schay J, Cox NJ, et al. Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians. J Clin Endocrinol Metab. 2002;87:650-4. (Pubitemid 34158232)
52. Rasmussen SK, Urhammer SA, Berglund L, Jensen JN, Hansen L, Echwald SM, et al. Variants within the calpain-10 gene on chromosome 2q37 (niddm1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians. Diabetes. 2002;51:3561-7. (Pubitemid 35407434)
53. Zheng J, Chen L, Li H. Relationship between calpain-10 gene polymorphism and insulin resistance phenotypes in Chinese. J Huazhong Univ Sci Technol Med Sci. 2004;24:452-5. (Pubitemid 41559561)
54. Kang SE, Kim HJ, Nam M, Nam CM, Ahm CW, Cha BS, et al. A novel 111/121 diplotype in the calpain-10 gene is associated with type 2 diabetes. J Hum Genet. 2006;51:629-33. (Pubitemid 44048697)
55. Chen SF, Lu XF, Yan WL, Huang JF, Gu DF. Variations in the calpain-10 gene are associated with the risk of type 2 diabetes and hypertension in northern Han Chinese population. Chin Med J. 2007;120:2218-23.
56. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet. 2000;26:163-75.
57. Cassell PG, Jackson AE, North BV, Evans JC, Syndercombe-Court D, Phillips C, et al. Haplotype combinations of calpain 10 gene polymorphisms associate with increased risk of impaired glucose tolerance and type 2 diabetes in South Indians. Diabetes. 2000;51:1622-8. (Pubitemid 34826634)
58. Adak S, Sengupta S, Chowdhury S, Bhattacharya M. Coexistence of risk and protective haplotypes of calpain 10 gene to type 2 diabetes in the eastern Indian population. Diab Vasc Dis Res. 2010;7:63-8.
59. Mancini FP, Vaccaro O, Sabatino L, Tufano A, Rivellese A, Riccardi G, et al. Pro12Ala substitution in the peroxisome proliferator-activated receptor-γ2is not associated with type 2 diabetes. Diabetes. 1999;48:1466-8. (Pubitemid 29297312)
60. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000;26:76-80.
61. Hara K, Okadab T, Tobe K, Yasuda K, Morib Y, Kadowakia H, et al. The Pro12Ala polymorphism in ppar gamma 2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun. 2000;271:212-6. (Pubitemid 30444879)
62. Douglas JA, Erdos MR, Watanabe RM, Braun A, Johnston CL, Oeth P, et al. The peroxisome proliferator-activated receptorgamma2 Pro12Ala variant: association with type 2 diabetes and trait differences. Diabetes. 2001;50:886-90. (Pubitemid 32242649)
63. Pinterova D, Cerna M, Kolostova K, Novota P, Cimburova M, Romzova M, et al. The frequency of alleles of the Pro12Ala polymorphism in PPARγ2 is different between healthy controls and patients with type 2 diabetes. Folia Biol Praha. 2004;50:153-6. (Pubitemid 39545691)
64. Radha V, Vimaleswaran KS, Babu HN, Abate N, Chandalia M, Satija P, et al. Role of genetic polymorphism peroxisome proliferator-activated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: evidence for heterogeneity. Diabetes Care. 2006;29:1046-51. (Pubitemid 44115242)
65. Gloyn AL, Hashim Y, Ashcroft SJ, Asheld R, Wiltshire S, Turner RC. Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53). Diabet Med. 2001;18:206-12. (Pubitemid 32397858)
66. Gloyn AL, Weedon MN, Owen KR, Turner MJ, Knight BA, Hitman G, et al. Large-scale association studies of variants in genes encoding the pancreatic beta cell KATP channel subunits KIR6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2diabetes. Diabetes. 2003;52:568-72. (Pubitemid 36173218)
67. Koo BK, Cho YM, Park BL, Cheong HS, Shin HD, Jang HC, et al. Polymorphisms of KCNJ11 (Kir6.2 gene) are associated with Type 2 diabetes and hypertension in the Korean population. Diabet Med. 2007;24:178-86. (Pubitemid 46174942)
68. Alsmadi O, Al-Rubeaan K, Wakil SM, Imtiaz F, Mohamed G, Al-Saud H, et al. Genetic study of Saudi diabetes (GSSD): significant association of the KCNJ11 E23K polymorphism with type 2 diabetes. Diab Metab Res Rev. 2008;24:137-40. (Pubitemid 351284758)
69. Radha V, Vimaleswaran KS, Ayyappa KA, Mohan V. Association of lipoprotein lipase gene polymorphisms with obesity and type 2 diabetes in an Asian Indian population. Int J Obes. 2007;31:913-8. (Pubitemid 46842691)
70. Cho YS, Go MJ, Han HR, Cha SH, Kim HT, Min H, et al. Association of lipoprotein lipase (LPL) single nucleotide polymorphisms with type 2 diabetes mellitus. Exp Mol Med. 2008;40:523-32. (Pubitemid 352789092)
71. Maegawa H, Shi K, Hidaka H, Iwai N, Nishio Y, Egawa K, et al. The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen - targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population. Diabetes. 1999;48:1469-72. (Pubitemid 29297313)
72. Farook VS, Hanson RL, Wolford JK, Bogardus C, Prochazka M. Molecular analysis of KCNJ10 on 1q as a candidate gene for type 2 diabetes in Pima Indians. Diabetes. 2002;51:3342-6. (Pubitemid 35246984)
73. Qi L, Van Dam RM, Meigs JB, Manson JE, Hunter D, Hu FB. Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and metaanalysis. Hum Mol Genet. 2006;15:1914-20. (Pubitemid 43821781)
74. Rasmussen SK, Urhammer SA, Pizzuti A, Echwald SM, Ekstrom CT, Hansen L, et al. The K121Q variant of the human PC-1 gene is not associated with insulin resistance or type 2 diabetes among Danish Caucasians. Diabetes. 2000;49:1608-11.
75. Abate N, Chandalia M, Satija P, Adams-Huet B, Grundy SM, Sandeep S, et al. ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes. Diabetes. 2005;54:1207-13. (Pubitemid 40446338)
76. Chen MP, Chung FM, Chang DM, Tsai JCR, Huang HF, Shin SJ, et al. ENPP1 K121Q polymorphism is not related to type 2 diabetes mellitus, features of metabolic syndrome, and diabetic cardiovascular complications in a Chinese population. Rev Diabet Stud. 2006;3:21-30.
77. Seo HJ, Kim SG, Kwon OJ. The K121Q polymorphism in ENPP1 (PC-1) is not associated with type 2 diabetes or obesity in korean male workers. J Korean Med Sci. 2008;23:459-64.
78. Andersen G, Rose CS, Hamid YH, Drivsholm T, Borch-Johnsen K, Hansen T, et al. Genetic variation of the GLUT10 glucose transporter (SLC2A10) and relationships to type 2 diabetes and intermediary traits. Diabetes. 2003;52:2445-8. (Pubitemid 37059519)
79. Bento JL, Bowden DW, Mychaleckyj JC, Hirakawa S, Rich SS, Freedman BI, et al. Genetic analysis of the GLUT10 glucose transporter (SLC2A10) polymorphisms in Caucasian American type 2 diabetes. BMC Med Genet. 2005;6:42.
80. Karim MA, Wang X, Hale TC, Elbein SC. Insulin promoter factor 1 variation is associated with type 2 diabetes in African Americans. BMC Med Genet. 2005;6:37.
81. Furuta H, Furuta M, Sanke T, Ekawa K, Hanabusa T, Nishi M, et al. Nonsense and missense mutations in the human hepatocyte nuclear factor-1 beta gene (TCF2) and the irrelation to type 2 diabetes in Japanese. J Clin Endocrinol Metab. 2002;87:3859-63. (Pubitemid 34879539)
82. Hara K, Horikoshi M, Kitazato H, Ito C, Noda M, Ohashi J, et al. Hepatocyte Nuclear Factor-4 alpha P2 promoter haplotypes are associated with type 2 diabetes in the Japanese population. Diabetes. 2006;55:1260-4. (Pubitemid 44195362)
83. Silander K, Mohlke KL, Scott LJ, Peck EC, Hollstein P, Skol AD, et al. Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes. Diabetes. 2004;53:1141-9. (Pubitemid 38436630)
84. Vimaleswaran KS, Radha V, Ghosh S, Majumder PP, Deepa R, Babu HNS, et al. Peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) gene polymorphisms and their relationship to type 2 diabetes in Asian Indians. Diabet Med. 2005;22:1516-21. (Pubitemid 41641158)
85. Bhat A, Koul A, Rai E, Sharma S, Dhar MK, Bamezai RN. PGC-1 alpha Thr394Thr and Gly482Ser variants are significantly associated with T2DM in two North Indian populations: a replicate case-control study. Hum Genet. 2007;121:609-14. (Pubitemid 46706072)
86. Laasko M, Malkki M, Kekalainen P, Kuusisto J, Deeb SS. Insulin receptor substrate-1 variants in non-insulin-dependent diabetes. J Clin Invest. 1994;94:1141-6. (Pubitemid 24286456)
87. Kovacs P, Hanson RL, Lee YH, Yang X, Kobes S, Permana PA, et al. The role of insulin receptor substrate-1 gene (IRS1) in type 2 diabetes in Pima Indians. Diabetes. 2003;52:3005-9. (Pubitemid 37466873)
88. Florez JC, Sjogren M, Agapakis CM, Burtt NP, Almgren P, Lindblad U, et al. Association testing of common variants in the insulin receptor substrate-1 gene (IRS1) with type 2 diabetes. Diabetologia. 2007;50:1209-17. (Pubitemid 46701562)
89. Liu Y, Zhou DZ, Zhang D, Chen Z, Zhao T, Zhang Z, et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes in the population of mainland China. Diabetologia. 2009;52:1315-21.
90. Van Hoek M, Dehghan A, Zillikens MC, Hofman A, Witteman JC, Sijbrands EJG. An RBP4 promoter polymorphism increases risk of type 2 diabetes. Diabetologia. 2008;51:1423-8.
91. Traurig M, Hanson RL, Kobes S, Bogardus C, Baier LJ. Protein tyrosine phosphatase 1B is not a major susceptibility gene for type 2 diabetes mellitus or obesity among Pima Indians. Diabetologia. 2007;50:985-9. (Pubitemid 46559249)
92. Dixit M, Bhattacharya S, Mittal B. Association of CETP TaqI and APOE polymorphisms with type II diabetes mellitus in North Indians: a case control study. BMC Endocr Disord. 2005;5:7.
93. Moller AM, Jensen NM, Pildal J, Drivsholm T, Borch-Johnsen K, Urhammer SA, et al. Studies of genetic variability of the glucose transporter 2 promoter in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2001;86:2181-6. (Pubitemid 32472937)
94. Yajnik CS, Janipalli CS, Bhaskar S, Kulkarni SR, Freathy RM, Prakash S, et al. FTO gene variants are strongly associated with type 2 diabetes but only weakly with obesity in South Asian Indians. Diabetologia. 2009;52:247-52.
95. Zenibayashi M, Miyake K, Horikawa Y, Hirota Y, Teranishi T, Kouyama K, et al. Lack of asssociation of LRP5 and LRP6 polymorphisms with type 2 diabetes mellitus in the Japanese Population. Endocr J. 2008;55:699-707.
96. Bodhini D, Radha V, Deepa R, Ghosh S, Majumder PP, Rao MRS, et al. The G1057D polymorphism of IRS-2 gene and its relationship with obesity in conferring susceptibility to type 2 diabetes in Asian Indians. Int J Obes. 2007;31:97-102. (Pubitemid 46006021)
97. Wang H, Rissanen J, Miettinen R, Karkkainen P, Keka lainen P, Kuusisto J, et al. New amino acid substitutions in the IRS-2 gene in Finnish and Chinese subjects with late-onset type 2 diabetes. Diabetes. 2001;50:1949-51. (Pubitemid 33641618)
98. Bid HK, Konwar R, Agrawal CG, Banerjee M. Association of IL-4 and IL-1RN (receptor antagonist) gene variants and the risk of type 2 diabetes mellitus: a study in the north Indian population. Indian J Med Sci. 2008;62:259-66.
99. Tong Y, Lin Y, Zhang Y, Yang Y, Zhang Y, Liu H, et al. Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis. BMC Med Genet. 2009;10:15.
100. Cauchi S, EI Achhab Y, Choquet H, Dina C, Krempler F, Weitgasser R, et al. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med. 2007;85:777-82. (Pubitemid 47063530)
101. Gerbitz KD, van den Ouwelandb JM, Maassenb JA, Jaksch M. Mitochondrial diabetes mellitus: a review. Biochim Biophys Acta. 1995;24:253-60.
102. Feder J, Ovadia O, Blech I, Cohen J, Wainstein J, Harman-Boehm I, et al. Parental diabetes status reveals association of mitochondrial DNA haplogroup J1 with type 2 diabetes. BMC Medl Genet. 2009;10:60.
103. Fuku N, Park KS, Yamada Y, Nishigaki Y, Cho YM, Matsuo H, et al. Mitochondrial Haplogroup N9a confers resistance against type 2 diabetes in Asians. Am J Hum Genet. 2007;80:407-15.
104. Bhat A, Koul A, Sharma S, Rai E, Bukhari SI, Dhar MK, et al. The possible role of 10398A and 16189 C mtDNA variants in providing susceptibility toT2DM in two North Indian populations: a replicative study. Hum Genet. 2007;120:821-6. (Pubitemid 46128837)
105. Baier LJ, Hanson RL. Genetic studies of the etiology of type 2 diabetes in Pima Indians. Diabetes. 2004;53:1181-6.
106. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007;445:881-5.
107. Salonen JT, Uimari P, Aalto JM, Pirskanen M, Kaikkonen J, Todorova B, et al. Type 2 diabetes whole-genome association study in four populations: dhe DiaGen consortium. Am J Hum Genet. 2007;81:338-45. (Pubitemid 47236080)
108. Horikawa Y, Miyake K, Yasuda K, Enya M, Hirota Y, Yamagata K, et al. Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. J Clin Endocrinol Metab. 2008;93:3136-41.
109. Omori S, Tanaka Y, Takahashi A, Hirose H, Kashiwagi A, Kaku K, et al. Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2diabetes in a Japanese population. Diabetes. 2008;57:791-5.
110. Tabara Y, Osawa H, Kawamoto R, Onuma H, Shimizu I, Miki T, et al. Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes. 2009;58:493-8.
111. Ng MC, Park KS, Oh B, Tam CH, Cho YM, Shin HD, et al. Implications of genetic variants near TCF7L2, SLC30A8, HHEX, CDKALI, CDKN2A/B, IGF2BP2 and FTO in type 2 diabetes and obesity in 6, 719 Asians. Diabetes. 2008;57:2226-33.
112. Lewis JP, Palmer ND, Hicks PJ, Sale MM, Langefeld CD, Freedman BI, et al. Association analysis in african americans of Europeanderived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies. Diabetes. 2008;57:2220-5.
113. Hu C, Zhang R, Wang C, Wang J, Ma X, Lu J, et al. PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population. PLoS ONE. 2009;4:e7643.
114. Tsai FJ, Yang CF, Chen CC, Chuang LM, Lu CH, Chang CT, et al. A genome-wide association study identifies susceptibility variants for type 2 diabetes in HanChinese. PLoS ONE. 2010;6:e1000847.
115. Wen J, Ronn T, Olsson A, Yang Z, Lu B, Du Y, et al. Investigation of type 2 diabetes risk alleles support CDKN2A/B, CDKAL1 and TCF7L2 as susceptibility genes in a Han Chinese Cohort. PLoS ONE. 2010;5:e9153.
116. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010;42:579-89.
117. Manolio TA, Feero WG, Guttmacher AE. Genome wide association studies and assessment of the risk of disease. N Engl J Med. 2010;363:166-76.
118. Kowall B, Rathmann W, Strassburger K, Heier M, Holle R, Thorand B, et al. Association of passive and active smoking with incident type 2 diabetes mellitus in the elderly population: the KORA S4/F4 cohort study. Eur J Epidemiol. 2010;25:393-402.
119. Joosten MM, Grobbee DE, van der ADL, Verschuren WM, Hendriks HF, Beulens JW. Combined effect of alcohol consumption and lifestyle behaviors on risk of type 2 diabetes. Am J Clin Nutr. 2010;91:1777-83.
120. Fu J, Binyou W, Terry C. A new approach to the study of diet and risk of type2 diabetes. J Postgrad Med. 2007;53:139-43. (Pubitemid 46808820)
121. Abate N, Chandalia M. Ethnicity, type 2 diabetes & migrant Asian Indians. Indian J Med Res. 2007;125:251-8. (Pubitemid 46805446)
122. Sudha V, Radhika G, Mohan V. Current dietary trends in the management of diabetes. Indian J Med Res. 2004;120:4-8. (Pubitemid 39172812)
123. Mitra A, Bhattacharya D, Roy S. Dietary influence on Type 2 Diabetes (NIDDM). J Hum Ecol. 2007;21:139-47.
124. Misra A, Khurana L, Isharwal S, Bhardwaj S. South Asian diets and insulin resistance. Br J Nutr. 2009;101:465-73.
125. Isharwal S, Misra A, Wasir JS, Nigam P. Diet & insulin resistance: a review & Asian Indian perspective. Indian J Med Res. 2009;129:485-99.
126. Padmanabhan S, Menni C, Prabhakaran D, Dominiczak AF. Discovering the genetic determinants of complex diseases. Curr Sci. 2009;97:391-5.
127. Dedoussis GVZ, Kaliora AC, Panagiotakos DB. Genes, diet and type 2 diabetes mellitus: a review. Rev Diabet Stud. 2007;3:13-24. (Pubitemid 47450221)
128. Cornelis MC, Qi L, Kraft P, Hu FB. TCF7L2, dietary carbohydrate, and risk of type 2 diabetes in US women. Am J Clin Nutr. 2009;89:1256-62.
129. Ruchat SM, Elks CE, Loos RJ, Vohl MC, Weisnagel SJ, Rankinen T, et al. Evidence of interaction between type 2 diabetes susceptibility genes and dietary fat intake for adiposity and glucose homeostasis-related phenotypes. J Nutrigenet. 2009;2(4-5):225-34. Epub 2010.
130. Memisoglu A, Hu FB, Hankinson SE, Manson JE, De Vivo I, Willett WC, et al. Interaction between a peroxisome proliferatoractivated receptor c gene polymorphism and dietary fat intake in relation to body mass. Hum Mol Genet. 2003;12:2923-9. (Pubitemid 37442020)
131. Eriksson JG, Osmond C, Lindi V, Uusitupa M, Orsen T, Laakso M, et al. Interactions between peroxisome proliferator-activated receptor gene polymorphism and birth length influence risk for type 2 diabetes. Diabetes Care. 2003;26:2476-7. (Pubitemid 36993353)
132. Ramaiya KL, Kodali VRR, Alberti KGMM. Epidemiology of diabetes in Asians of the Indian sub-continent. Intnl J Diab Dev Countries. 1991;11:15-36.
133. Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res. 2007;125:217-30. (Pubitemid 46805444)
134. Purty AJ, Vedapriya DR, Bazroy J, Gupta S, Cherian J, Viswanathan M. Prevalence of diagnosed diabetes in an urban area of Puducherry, India: time for preventive action. Int J Diab Dev Ctries. 2009;9:6-11.
135. Ramachandran A. Epidemiology of diabetes in Indians. Int J Diab Dev Ctries. 1993;13:65-7.
136. Mehta SR, Kashyap AS, Das S. Diabetes mellitus in India: the modern scourge. MJAFI. 2009;65:50-4.
137. Vijayakumar G, Arun R, Kutty VR. High prevalence of type 2 diabetes mellitus and other metabolic disorders in Rural Central Kerala. J Assoc Physicians India. 2009;57:563-7.
138. Sanghera DK, Nath SK, Ortega L, Gambarelli M, Kim-Howard X, Singh JR, et al. TCF7L2 polymorphisms are associated with type 2 diabetes in Khatri Sikhs from North India: genetic variation affects lipid levels. Ann Hum Genet. 2008;4:499-509. (Pubitemid 351833747)
139. Sanghera DK, Ortega L, Han S, Singh S, Ralhan SK, Wander GS, et al. Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk. BMC Med Genet. 2008;9:59.
140. Tabassum R, Chavali S, Dwivedi OP, Tandon N, Bharadwaj D. Genetic variants of FOXA2: risk of type 2 diabetes and effect on metabolic traits in North Indians. J Hum Genet. 2008;53:957-65.
141. Tabassum R, Chavali S, Mahajan A, Ghosh S, Madhu SV, Tandon N, et al. Association analysis of TNFRSF1B polymorphisms with type 2 diabetes and its related traits in North India. Genomic Med. 2008;2:93-100.
142. Chauhan G, Spurgeon CJ, Tabassum R, Bhaskar S, Kulkarni SR, Mahajan A, et al. Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 onthe risk of type 2 diabetes in 5, 164 Indians. Diabetes. 2010;59:2068-74.
143. Chidambaram M, Radha V, Mohan V. Replication of recently described type 2
144. Reich D, Thangaraj K, Patterson N, Price AL, Singh L. Reconstructing Indian population history. Nature. 2009;461:489-94.